| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K52037352 |
| PharmacoGx | BRD-K52037352 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GGCX | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | RUNDC3A | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | KDM1B | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | CTD-2574D22.6 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | ACTR10 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | ECE1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | SART3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | HEPH | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | VARS | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | MMP12 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
